Results 61 to 70 of about 1,831 (172)

Partially Expelled Necrotic Uterine Fibroid After Relugolix Combination Therapy: Case Report and Literature Overview on Adverse Effects of GnRH Antagonists

open access: yesCase Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.
Background and Clinical Significance Relugolix combination therapy (Relugolix CT) has emerged as an effective oral medical treatment for symptomatic uterine fibroids, offering an alternative to surgical interventions. While generally well tolerated, reports of adverse events beyond the common side effects are limited.
Laura Vona   +4 more
wiley   +1 more source

Norethindrone Acetate Enhances the Antiatherogenic Effect of 17β-Estradiol

open access: yes, 1998
—The influence of progestogens in combination with 17β-estradiol (E2) on cardiovascular disease remains controversial. This study investigated the effect of norethindrone acetate (NETA) combined with E2 on aortic atherosclerosis.
Irene Sandholdt   +5 more
core   +1 more source

Effects of oral, continuous and transdermal cyclic 17-? estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women

open access: yes, 2002
OBJECTIVE: To evaluate the affects of an oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate combination on platelet aggregation in postmenopausal women.
Yüce, MA   +4 more
core   +1 more source

Uterine “twisting sign”: A new potential ultrasonographic soft marker for deep endometriosis

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1355-1363, December 2025.
Abstract Objective The objective of the current study was to evaluate the “twisting sign,” defined as uterine fundus rotation observed on transvaginal sonography (TVS), as a potential soft marker for deep endometriosis (DE) and its association with specific DE localizations and indirect signs.
Fabio Barra   +7 more
wiley   +1 more source

Medical treatment of fibroids: FIGO best practice guidance

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 507-512, November 2025.
Abstract Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin‐releasing hormone (GnRH) antagonists have been approved for this
Ivonne Diaz   +2 more
wiley   +1 more source

Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?

open access: yes, 2019
Objective: To compare the effects of Dienogest (D)and Norethindrone acetate (N)in symptomatic women with ovarian endometriomas, analyzing the efficacy in reducing endometrioma size and symptom relief and drug tolerability.
Arena A.   +6 more
core   +1 more source

Energy balance in cyclists on plant‐based diets during a 30‐day, 4300‐km ride across Canada: Two case studies

open access: yesPhysiological Reports, Volume 13, Issue 21, November 2025.
Abstract The popularity of ultra‐endurance events and plant‐based diets highlights the importance of understanding the energetics of athletes with diverse dietary preferences. This study examined energy balance in two recreational cyclists on plant‐based diets (male, 41 years; female, 38 years) during a 30‐day cross‐Canada ride.
Sarah A. Purcell   +6 more
wiley   +1 more source

Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue S4, September 2025.
ABSTRACT Background The decline in estrogen during menopause contributes to structural and functional skin changes, including decreased collagen production, reduced elasticity, and moisture loss, resulting in dryness and wrinkling. Today, hormone replacement therapy (HRT) enhances skin quality by promoting collagen synthesis, elasticity, and hydration.
Bianca Viscomi   +2 more
wiley   +1 more source

The science at HIVR4P 2024: The era of choice in biomedical HIV prevention

open access: yesJournal of the International AIDS Society, Volume 28, Issue 7, July 2025.
ABSTRACT Introduction HIVR4P 2024, the 5th HIV Research for Prevention Conference, took place in Lima, Peru, 6–10 October 2024. The conference focused on new developments in HIV prevention from basic research to new product development and implementation science.
Beatriz Grinsztejn   +26 more
wiley   +1 more source

Recent Developments in Deep Eutectic Solvents Applications in Liquid Chromatography: 2019–2025

open access: yesJournal of Separation Science, Volume 48, Issue 5, May 2025.
ABSTRACT Deep eutectic solvents (DES) are used as mobile phase and stationary phase modifiers, or as for the stationary phase itself for thin layer/liquid/supercritical chromatography. Their specific properties can improve the separation selectivity, reduce peak tailing, and shorten the separation time.
Derya Demir   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy